Cartesian Therapeutics, Inc. — Director's Dealing 2016

Aug 2, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-07-29

Reporting Person: BARABE TIMOTHY C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-29	Stock Option (Right to Buy)	$10.99	A	12820	Acquired	2026-07-28	Common Stock (12820)	Direct

Footnotes

F1: The option vests in thirty-six (36) substantially equal monthly installments over three years following the date of grant.